Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Before borrowing money for credit card debt, consider the interest rates and repayment terms. Make informed decisions to avoid further financial strain.
23,246 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A Supreme Court ruling nullifies broad tariffs, but a mid-sized U.S. coffee roaster warns refunds are unlikely and co...
A major hedge fund recently boosted its Garrett Motion position, highlighting how hybrid powertrain trends are reshap...
Snowflake has delivered strong results, yet the stock has pulled back. This guide explains what snowflake shows signs...
Bitcoin surged to an intraday high near $74,000 on a choppy trading day, but traders warn that a sustained drop below...
As market conditions shift in March 2026, traders seek better tools and pricing. This guide highlights the best SoFi ...
Anthropic's study identifies which roles are most exposed to AI, warning of wage pressure and hiring shifts as automa...
Federal regulators are pulling nearly 90,000 bottles of children's ibuprofen from shelves after reports of foreign ma...
Investors debating the better crypto buy: bitcoin face a choice between owning Bitcoin outright or stepping into a Bi...
AI-driven infrastructure growth is lifting semiconductor ETFs and a broad set of chipmakers. The wave is broadening b...
The latest Goldman Sachs retirement survey finds a gap between savers’ targets and retirees’ realities, prompting a c...
A leading Wall Street chartist warns that US tech concentration has reached levels not seen since the dot-com bubble,...